THE PREVALENCE OF OCCULT HEPATITIS B AMONG HBSAG-NEGATIVE PERSONS WITH HIV IN VELIKY NOVGOROD
-
Published:2019-04-07
Issue:1
Volume:11
Page:64-70
-
ISSN:2077-9828
-
Container-title:HIV Infection and Immunosuppressive Disorders
-
language:
-
Short-container-title:VIČ-infekc. immunosupr.
Author:
Ostankova Yu. O.1, Semenov A. V.2, Zueva E. B.1, Totolian A. A.3
Affiliation:
1. Saint-Petersburg Pasteur Institute 2. Saint-Petersburg Pasteur Institute; First St. Petersburg state medical University named after academician I. P. Pavlov; North-West State Medical University named after I.I.Mechnikov, Saint-Petersburg 3. Saint-Petersburg Pasteur Institute; First St. Petersburg state medical University named after academician I. P. Pavlov
Abstract
Aim: to estimate the prevalence of the occult hepatitis B virus among HIV-infected patients with the virological ineffectiveness of antiretroviral therapy in Veliky Novgorod. Materials and methods. Blood plasma samples from 76 HBsAg-negative HIVinfected patients with virological inefficiency of antiretroviral therapy from Veliky Novgorod were used in the work. For the detection of the hepatitis B virus, nucleic acids were isolated using the commercial kit AmplePrime Ribo-prep. For amplification and sequencing, overlapping pairs of specific primers were used, jointly flanking a 1475 base pair fragment including the 1169 base pair Pre-S1/Pre-S2/S region recommended for genotyping the hepatitis B virus. Results. Among 76 samples of hepatitis B virus DNA, 44 samples were found, which was 57,89%. None of the patients had HBsAg, and 6 patients (13,63%) had HBcor IgG and HBe IgG antibodies. On the basis of phylogenetic analysis, it was shown that only genotype D, which is the most common genotype of the hepatitis B virus in the Russian Federation, was detected in the examined group. The subgenotype D2 (47,72%) prevailed in comparison with the subgenotype D1 (34,09%) and the subgenotype D3 (18,18%). The distribution possible ways of the subgenotype D1 hepatitis B virus, which is uncharacteristic for the region, are discussed. Only one isolate of hepatitis B virus with mutations of drug resistance to nucleotide / nucleoside analogue therapy has been identified — amino acid substitution in the polymerase gene of the virus (L180M, M204V) associated with the development of resistance to lamivudine, entecavir, telbivudine and tenofovir. Conclusion. The high prevalence of occult hepatitis B among HIVinfected patients indicates a lack current tests for the diagnosis of chronic HBV infections. The identification of occult hepatitis B in HIV-infected individuals seems appropriate for timely treatment of patients and requires the use more sensitive methods.
Publisher
Baltic Medical Education Center
Subject
Infectious Diseases,Public Health, Environmental and Occupational Health,Immunology
Reference25 articles.
1. Yim H.J., Lok A.S. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology, 2006, Vol. 43, No. Suppl. 1, pp. S173–S181. URL: DOI: 10.1002/hep.20956. 2. Raimondo G., Allain J. P., Brunetto M.R., Buendia M.A., Chen D.S., Colombo M., Craxi A., Donato F., Ferrari C., Gaeta G.B., Gerlich W.H., Levrero M., Locarnini S., Michalak T., Mondelli M.U., Pawlotsky J.M., Pollicino T., Prati D., Puoti M., Samuel D., Shouval D., Smedile A., Squadrito G., Trepo C., Villa E., Will H., Zanetti A.R., Zoulim F. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J. Hepatol., 2008, Vol. 49, pp. 652–657. URL: DOI: 10.1016/j.jhep.2008.07.014. 3. Semenov A.V., Ostankova Yu.V., Faizullaev Kh.N., Kazakova E.I., Kozlov A.V., Musabaev E.I., Totolyan Areg A. HBV covalently closed circular DNA as a marker of prevalence of occult hepatitis В in patients with HBV, HDV and HCV infection in Uzbekistan. Journal of Microbiology, Epidemiology and Immunobiology, 2016, No. 5, pp. 43–49 (In Russ.) 4. Samal J., Kandpal M., Vivekanandan P. Molecular mechanisms underlying occult hepatitis B virus infection. Clin. Microbiol. Rev., 2012, Vol. 25, pp. 142–163. URL: DOI: 10.1128/CMR.00018-11. 5. Joint United Nations Programme on HIV/AIDS, United Nations. Global Report: UNAIDS Report on the Global AIDS epidemic. Geneva: UNAIDS, 2012, 212 p. URL: http://www.unaids.org/en/resources/documents/2012/20121120_UNAIDS_Global_Report_2012.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|